In the functionally differentiated mammary gland, basal myoepithelial cells contract to eject the milk produced by luminal epithelial cells from the body. We report that conditional deletion of a laminin receptor, a3b1 integrin, from myoepithelial cells leads to low rates of milk ejection due to a contractility defect but does not interfere with the integrity or functional differentiation of the mammary epithelium. In lactating mammary gland, in the absence of a3b1, focal adhesion kinase phosphorylation is impaired, the Rho/Rac balance is altered and myosin light-chain (MLC) phosphorylation is sustained. Cultured mammary myoepithelial cells depleted of a3b1 contract in response to oxytocin, but are unable to maintain the state of post-contractile relaxation. The expression of constitutively active Rac or its effector p21-activated kinase (PAK), or treatment with MLC kinase (MLCK) inhibitor, rescues the relaxation capacity of mutant cells, strongly suggesting that a3b1-mediated stimulation of the Rac/PAK pathway is required for the inhibition of MLCK activity, permitting completion of the myoepithelial cell contraction/relaxation cycle and successful lactation. This is the first study highlighting the impact of a3b1 integrin signalling on mammary gland function.
Introduction
Integrins are ab heterodimeric adhesion receptors that connect the extracellular matrix (ECM) to the actin cytoskeleton within structures called focal adhesions. These structures stabilize the cytoskeleton and serve as a platform for the assembly of multimolecular complexes mediating activation of intracellular signalling pathways involved in the control of proliferation, survival, differentiation, motility and other cellular functions (Hynes, 2002; Vincente-Manzanares et al, 2009) . Integrin-mediated signalling has an essential role in the activation of small Rho-GTPases, such as Rho and Rac, major regulators of actin cytoskeleton and cell-cell and cell-ECM adhesion (reviewed in Huveneers and Danen (2009) ).
The mammary epithelium consists of two layers of epithelial cells: the luminal and basal layers. In functionally differentiated mammary gland, i.e., during lactation, luminal cells produce and secrete milk, whereas basal cells, also referred to as myoepithelial cells, contract to force milk out of the body. Mammary myoepithelial cells are characterized by a dual differentiation program. On the one hand, these cells express numerous markers shared by basal cells from various stratified epithelia. On the other hand, they express high levels of smooth muscle (SM)-specific contractile and cytoskeletal proteins responsible for the contractile activity of the myoepithelium. Inactivation of the gene coding for myocardin-related transcription factor regulating the expression of the SM-contractile proteins perturbs differentiation of the mammary myoepithelial cells resulting in impaired lactation (Li et al, 2006; Sun et al, 2006) .
The basal epithelial cell layer interacts directly with the mammary basement membrane, a specialized ECM structure underlying the mammary epithelium, and integrins of the b1 family and a6b4 are major ECM receptors expressed by mammary epithelial cells (Taddei et al, 2003) . Several studies have suggested that b1 integrins participate in the control of growth and differentiation of the mammary epithelium in vivo and have an essential role in the maintenance of the mammary stem cell population (Faraldo et al, 1998; Li et al, 2005; Taddei et al, 2008) . The b1 integrin chain binds various a subunits, and the ECM ligand specificity of the resulting dimer depends on the nature of the a subunit. Different integrin dimers may activate different intracellular signalling pathways affecting cellular functions in a context-dependent manner (Huveneers and Danen, 2009 ). The laminin receptor a3b1 is one of the major integrins expressed in basal mammary epithelial cells. Germinal deletion of the a3 integrin chain leads to early postnatal lethality due to abnormal kidney and lung development (Kreidberg et al, 1996) . Several recent studies using conditional a3-knockout mice have addressed the functions of a3b1 integrin in various tissues. Deletion of the a3 integrin chain from the epidermis indicated that a3b1 integrin inhibited directional migration and wound healing in the skin (Margadant et al, 2009) . a3b1 integrin was found to control expression of the pro-angiogenic factor MRP3 in keratinocytes, promoting endothelial cell migration and wound angiogenesis (Mitchell et al, 2009) . Conditional deletion from endothelial cells revealed a role for a3b1 integrin in the regulation of angiogenesis (da Silva et al, 2010) . a3b1 integrin was found to interact with netrin1 and to modulate routes of interneuronal migration in the developing cerebral cortex (Stanco et al, 2009 ). Analysis of the role played by a3b1 integrin in mammary morphogenesis, based on the transplantation of epithelium into the cleared mouse mammary fat pad, led to the conclusion that a3b1 integrin might be dispensable for mammary development (Klinowska et al, 2001 ). However, this study neither examined the potential function of a3b1 integrin during lactation, nor investigated the impact of a3b1-mediated signalling events on the functional activity of the mammary epithelium.
To study the role played by a3b1 integrin in mammary epithelium in vivo, we deleted itga3 from the mammary basal cell layer using Cre-Lox approach. We show here that ablation of itga3 neither interfered with mammary morphogenesis, nor impeded the functional differentiation of mammary epithelial cells. However, mice harbouring a3b1-deficient myoepithelium could not lactate normally due to a myoepithelial cell contractility defect associated with altered Rho/Rac balance. These results suggest that a3b1 integrinmediated signalling events have an essential role in the control of the amplitude and duration of the force developed by the myoepithelial cell contractile apparatus in lactating mammary gland and provide the first evidence highlighting the impact of a3b1 integrin signalling on mammary gland function.
Results

a3b1 integrin deletion from myoepithelial cells does not interfere with functional differentiation of the mammary epithelium
To delete the gene coding for a3 integrin chain, mice harbouring floxed itga3 alleles (itga3 F/F ) were crossed with transgenic mice expressing Cre recombinase under control of the keratin 5-promoter (K5Cre) active in the basal epithelial cells (Ramirez et al, 2004) . As expected, Cre-driven recombination was detected in the epidermis and mammary gland ( Figure 1A ). Ductal branching morphogenesis was not affected in mutant mice, although itga3 was found to be deleted from the mammary basal epithelial layer of 5-weekold animals (Supplementary Figure S1A-C). Immunoblotting and immunofluorescence analyses confirmed efficient deletion of the a3 integrin chain from the mammary epithelium of 1 day-lactating mutant mouse mammary glands ( Figure 1B and C) .
Overall, mutant mammary tissue organization was similar to that of control animals ( Figure 1C and D) . The expression and distribution of various integrin subunits (a6, b1 and b4) and ECM components (processed and unprocessed g2 laminin chain) were similar in control and mutant glands (Supplementary Figure S2A ; data not shown). Ultrastructural analysis of the mutant mammary epithelium revealed no defect in basal myoepithelial cell adhesion to the basement membrane (Supplementary Figure S2B) . These data suggest that, in the absence of a3b1, other integrin dimers present at the surface of the basal myoepithelial cells ensure adhesion to the ECM.
The functional differentiation of the mammary epithelium appeared normal in mutant glands, as shown by evaluation of the expression levels of milk and SM-contractile protein genes characteristic of luminal and myoepithelial cells, respectively, by quantitative RT-PCR ( Figure 1E ). Mammary epithelial cell proliferation was not affected in K5Cre;itga3 F/F glands, and hardly any apoptotic cells were detected with anti-cleaved caspase 3 antibody at the onset of lactation in control and mutant mammary epithelium (Supplementary Figure S2C-E; data not shown). Thus, the deletion of a3b1 integrin from myoepithelial cells did not affect the integrity and functional differentiation of the mammary epithelium.
K5Cre;itga3
F/F mice display lactation failure due to low rates of milk ejection K5Cre;itga3 F/F mutant mice were viable and fertile. However, the females were unable to feed their litters. About half the pups nursed by K5Cre;itga3 F/F females died within 4 days, and the surviving pups displayed severe growth retardation ( Figure 1F and G). Milk was visible in the stomachs of the pups fed by control females, whereas the pups nursed by K5Cre;itga3 F/F females appeared to have empty stomachs ( Figure 1F ). This defect was not intrinsic to the neonates, which developed normally after weaning or when nursed by control females. Control neonates fostered by lactating K5Cre;itga3 F/F females also failed to grow normally (data not shown). The mutant females presented no obvious abnormal maternal nurturing behaviour.
As milk was produced but not available to neonates, we hypothesized that the contractile activity of mutant myoepithelial cells was impaired, leading to a low rate of milk ejection. This hypothesis was supported by the results of morphological analyses of the lactating mouse glands. Most of the mutant glands analysed on days 7 and 18 of lactation contained large dilated ducts engorged with milk. In addition, collapsed alveoli and gland fragments displaying complete secretory tissue regression were found in mutant epithelium examined on day 18 of lactation ( Figure 2A ; data not shown). These morphological changes in the mutant glands were similar to those resulting from milk stasis, which is known to induce premature involution (Quarrie et al, 1996) .
High myosin light-chain phosphorylation level is maintained in lactating K5Cre;itga3 F/F mouse mammary glands The contraction of myoepithelial cells, like that of SM cells, is regulated by myosin light-chain (MLC) phosphorylation, which induces myosin ATPase activity, the binding of myosin to actin and contraction (Hartshorne et al, 1989) . The subsequent dephosphorylation of the MLC by its specific phosphatase (MLCP) leads to relaxation. Immunofluorescence analysis of MLC distribution showed this protein to be present in large amounts in the myoepithelial cells of control and mutant mammary epithelium ( Figure 2B , upper panels), whereas immunolabelling with antibodies against phosphorylated MLC was slightly stronger in mutant myoepithelial cells than in control cells ( Figure 2B , middle and lower panels). Immunoblotting analysis performed with protein extracts prepared from control and mutant mammary epithelium on the first day of lactation clearly demonstrated that MLC phosphorylation levels were abnormally high in mutant myoepithelial cells ( Figure 2C ).
Consistently, on the first day of lactation, the mutant myoepithelial cells presented extensions slightly shorter than those of control cells (data not shown) and, by day 5 of lactation, in most regions of the mutant glands, myoepithelial cells displayed a characteristic hypercontractile phenotype, with a compact cell body and short thick extensions ( Figure 2D and E) . In control tissue, most myoepithelial cells appeared more relaxed, with a significantly larger surface area and longer extensions ( Figure 2D and E). Taken together, these observations suggest that the MLC kinase/phosphatase activity balance is altered in mutant glands.
Mammary myoepithelial cell contraction requires activation of RhoA/ROCK pathway
In non-muscle and SM cells, MLC phosphorylation is controlled essentially by MLCK (Ikebe and Hartshorne, 1985; Somlyo and Somlyo, 2003; Webb, 2003) . The RhoA effector Rho kinase (ROCK) has also been reported to phosphorylate MLC in vitro, but the main effect of Rho/ROCK activation is the inhibitory phosphorylation of MLCP (Somlyo and Somlyo, 2003) .
During lactation, mammary myoepithelial cell contraction is induced by pulsatile release of the cyclic peptide oxytocin (OT), which binds to a promiscuous G protein-coupled receptor (OTR). The downstream signalling pathways leading To define whether ROCK has a role in myoepithelial cell contraction, fragments of mammary tissue dissected from 1 day-lactating mammary glands were treated with ROCK inhibitor and then incubated with OT. The changes in myoepithelial cell shape following OT treatment were analysed after labelling with anti-K5 antibody and phalloidin, by immunofluorescence microscopy. As previously reported, OT treatment induced major cell shape changes (Moore et al, 1987) . Relaxed myoepithelial cells had thin elongated processes, whereas OT-treated contracted cells had a compact spoke-shaped body with short, thick extensions ( Figure 3A and B). Pre-treatment with ROCK inhibitor (Y27632) abolished the myoepithelial cell response to OT ( Figure 3C ). Treatment with the inhibitor only did not lead to any visible cell shape changes ( Figure 3D ). Similar results were obtained with fragments of mammary tissue dissected from mutant glands (data not shown). These data suggest that OT-stimulated mammary myoepithelial cell contraction requires RhoA pathway activation.
Mammary myoepithelial cells depleted of a3b1 integrin are unable to complete the contraction/relaxation cycle
To define the molecular mechanisms involved in the regulation of mammary myoepithelial cell contraction by a3b1 integrin, we used a mouse myoepithelial cell line carrying conditional alleles of itga3 (MEC-a3 þ ) established in our laboratory. These cells express myoepithelial markers, including K5, a-SMA and P-cadherin, and are negative for luminal markers, such as K8 (Supplementary Figure S3A -C). The adenoviral delivery of Cre recombinase, followed by cell sorting with anti-a3 antibody, yielded myoepithelial cells lacking a3b1 integrin (MEC-a3À) (Figure 4A and B; Supplementary Figure S3D ). Flow cytometry analysis and adhesion assays revealed no major change in the surface expression of other integrin subunits or in adhesion properties of a3b1-deficient cells (Supplementary Figure S3D and E).
In agreement with the hypercontractile phenotype of mutant mammary myoepithelial cells observed in vivo, MEC-a3À showed an increased capacity to contract 3D collagen gels as compared with MEC-a3 þ cells (Supplementary Figure S4A ). However, both, MEC-a3 þ and MECa3À contracted collagen gels regardless of the presence of OT (not shown) precluding us from further analysis of the molecular mechanisms underlying the abnormal contractile phenotype of a3b1-deficient cells, in this model.
The contractile response of MEC-a3 þ and MEC-a3À to OT was analysed using time-lapse video microscopy. We have found that both, MEC-a3 þ and MEC-a3À cells responded to OT by a decrease in surface area in a dose-dependent manner ( Figure 4C and E, upper panels), and that most MEC-a3À, but not MEC-a3 þ cells responded to lower doses of OT ( Figure 4C ). Analysis of OT receptor transcript levels by quantitative RT-PCR revealed no statistically significant difference between MEC-a3 þ and MEC-a3À ( Figure 4D ), suggesting that the capacity of a3À cells to respond to lower doses of OT was not due to increased expression of OT receptor.
Importantly, the planar cell surface area did not change in response to OT, if MECs were pre-treated with an inhibitor of myosin ATPase, blebbistatin (Supplementary Figure S4B) , strongly indicating that the decrease of cell surface area can serve as the readout of cell contraction.
Consistent with the results obtained with lactating mouse mammary tissue fragments, the OT-induced contraction of MEC-a3 þ and MEC-a3À depended largely on ROCK. Indeed, pre-treatment with the ROCK inhibitor abolished OT-induced contraction (Figure 4E and F; Supplementary Movie 3). Thus, regardless of the presence of a3b1 integrin, the myoepithelial cell contractile response to OT involved activation of the RhoA pathway.
Treatment with 10 À9 M OT induced a contractile response in most MEC-a3 þ and MEC-a3À. This concentration was therefore chosen for further experiments. No significant difference was observed between MEC-a3 þ and MEC-a3À in terms of the time course and intensity of the primary contractile response, and a minimal surface area of 54.8 ± 1.6 and 51.9±1.4% of the initial area, for MEC-a3 þ and MECa3À, respectively, was reached about 6 min after stimulation (Figure 4E and F; Supplementary Table I) . Following contraction, MEC-a3 þ and MEC-a3À gradually recovered their initial surface area, with mean relaxation times of 20.2 ± 1.1 and 20.4±0.9 min, respectively. After relaxation, the surface area of most MEC-a3 þ remained constant, whereas about half the MEC-a3À failed to maintain the state of postcontraction relaxation and underwent additional contractions (Figure 4E and F; Supplementary Table I ; Supplementary Movies 1 and 2). These data are in keeping with the observation that high levels of MLC phosphorylation were maintained in lactating K5Cre;itga3 F/F mouse mammary gland. Thus, a3b1 integrin-mediated signalling is required for the accomplishment of the contraction cycle, i.e., MLC dephosphorylation and relaxation.
To study whether the regulation of the cell contractile function by a3b1 integrin involves its engagement at the cell surface, we pre-incubated MEC-a3 þ cells with a function-blocking anti-b1 integrin antibody before OT treatment. The anti-b1 integrin antibody induced additional contractions in MEC-a3 þ cells, phenocopying a3-deficient cells, and confirming that integrin interaction with its ECM ligands is essential for the control of the contraction/relaxation cycle in the myoepithelial cells (Supplementary Figure S4C ; Supplementary Table 1) .
a3b1-mediated stimulation of the FAK/Rac/PAK pathway is required for the inhibition of MLCK and the accomplishment of the myoepithelial cell contraction/relaxation cycle Focal adhesion kinase (FAK) controls Rho-family GTPase activation following integrin engagement (reviewed in Vincente-Manzanares et al (2009) and Huveneers and Danen (2009) ). We therefore analysed FAK phosphorylation levels in the immunoprecipitates obtained from 1 day-lactating mouse mammary gland protein extracts, with anti-FAK antibodies. The levels of total FAK phosphorylation (as estimated with an anti-PY antibody) and FAK autophosphorylation at tyrosine 397 (Y397) were considerably lower in mutant glands than in control tissue ( Figure 5A ), suggesting an impaired Rho-family GTPase activation.
Previous studies in keratinocytes have shown that a3b1-mediated signalling may lead to Rac activation (Choma et al, 2004 (Choma et al, , 2007 Hamelers et al, 2005) . In the extracts obtained from 1 day-lactating K5Cre;itga3 F/F mouse mammary glands, the level of active Rac was found to be significantly lower than in control tissue, whereas the level of Rho activation was higher in mutant gland extracts than in control ( Figure 5B) . In untreated and OT-treated MEC-a3À, Rac activation levels were found to be significantly decreased as compared with MEC-a3 þ ( Figure 5C ). As expected, OT stimulation did not affect Rac activation but resulted in significant increase of active Rho levels in control MEC-a3 þ and MEC-a3À. However, prior, as well as after OT treatment, active Rho levels in MEC-a3À were similar to those of MEC-a3 þ ( Figure 5C ). Western blot analyses of extracts prepared from 1 day-lactating mouse mammary glands and cultured MECs did not reveal any a3b1-dependent significant differences in Rac and Rho protein levels (Supplementary Figure  S5A and B; data not shown). Altogether, these data indicate that the Rho/Rac activity balance is altered in a3b1 integrindeficient mammary myoepithelial cells.
Next, we investigated the effect of Rac inhibition on the contractile response of MEC to OT. The treatment of control MEC-a3 þ with Rac inhibitor NSC23766 before OT stimulation induced additional contractions after the primary contractile response (Figure 5D and E; Supplementary Table I; Supplementary Movie 4). Similarly, the expression of dominant-negative Rac (Rac N17 ) in MEC-a3 þ led to additional contractions (Figure 5D and E; Supplementary Figure  S5C ; Supplementary Table I; Supplementary Movie 5). The p21-activated kinase (PAK) is a downstream effector of Rac signalling (Bagrodia and Cerione, 1999) . Expression of dominant-negative PAK (PAK DN ) or its silencing with shRNA (PAK-sh) leading to approximately two-fold decrease of initial PAK protein levels, induced additional contractions in control MEC-a3 þ cells (Figure 5D and E; Supplementary  Figure S5D and E; Supplementary Movie 6). Thus, inhibition of the Rac/PAK pathway phenocopied the lack of a3b1 integrin in MEC. The pre-treatment of MEC-a3À with Rac inhibitor had only a minor effect on the response to OT, suggesting that Rac activity might already be inhibited in the absence of a3b1 (Supplementary Figure S5F) . We then obtained MEC-a3À expressing a constitutively active form of Rac, Rac V12 , or a catalytically active form of PAK, PAK CA (Supplementary Figure S5G and H). Expression of Rac V12 or PAK CA in MEC-a3À prevented additional contractions, with about 80% of the cells remaining stable after the primary contractile response (Figure 5F and G; Supplementary Table I; Supplementary Movies 7 and 8). Thus, activation of the Rac/PAK signalling pathway rescued the abnormal phenotype caused by a lack of a3b1 integrin. Several studies have demonstrated that PAK can affect myosin contractile function by phosphorylating and inhibiting MLCK (Sanders et al, 1999; Goeckeler et al, 2000; Murthy et al, 2003; Wirth et al, 2003) . We, therefore, investigated whether reducing MLCK activity restored the relaxation capacity of MEC-a3À cells. As expected, pre-treatment of MECs with 10 mM of the MLCK inhibitor ML7, prevented the OT-induced contraction (data not shown). However, treatment with a low dose of ML7 (1 mM) did not interfere with primary contractile response of MEC-a3 þ and MECa3À and had only minor effect on MEC-a3 þ post-contraction relaxation (data not shown; Figure 5H ; Supplementary  Table I) . Strikingly, treatment of MEC-a3À with 1 mM ML7 led to the restoration of their relaxation capacity, such that B70% of the cells remained stable after the primary contraction ( Figure 5H ; Supplementary Table I; Supplementary Movie 9). These results suggest that a3b1 integrin-deficient cells display an increase in MLCK activity, leading to abnormally high MLC phosphorylation levels and impaired relaxation.
In concert, these data strongly indicate that, in the absence of a3b1 integrin, Rac activation is impaired, leading to the maintenance of MLC phosphorylation and impeding myoepithelial cell relaxation. This incomplete contraction/ relaxation cycle should prevent subsequent full-strength contractions, accounting for the lower milk ejection rates observed in K5Cre;itga3 F/F mice.
Discussion
In this study, to analyse the functions of a3b1 integrin in mammary development and functional differentiation of mammary epithelial cells, we have deleted the itga3 gene specifically from the mammary basal epithelial cell layer. In agreement with previous data, mammary ductal branching and lobulo-alveolar development were not perturbed in mutant mice (Klinowska et al, 2001) . We also showed that, similarly to control cells, by the onset of lactation, mutant mammary myoepithelial cells attained a differentiated state and expressed SM-specific contractile proteins. As expected, the differentiation of luminal secretory cells was not affected in mutant epithelium, and expression levels of milk protein genes were similar to those of control animals. Nevertheless, the lack of a3b1 integrin led to a perturbation of intracellular signalling events essential for myoepithelial cell contractile activity resulting in lactation failure. In mutant mammary tissue, FAK and Rac activation were impaired, whereas MLC phosphorylation levels were significantly higher than in control tissue. Consistent with these observations, cultured mammary myoepithelial cells depleted of a3b1 were unable to maintain the state of post-contraction relaxation. The abnormal phenotype of mutant cells was rescued by the expression of activated Rac or PAK or by inhibiting MLCK activity. These results strongly suggest that a3b1 integrin-mediated activation of the FAK/Rac/PAK signalling pathway is required for the inhibition of MLCK activity and the relaxation of mammary myoepithelial cells.
The scheme presented in Figure 6 summarizes the intracellular signalling events essential for mammary myoepithelial cell contractile activity and illustrates the contribution of a3b1 integrin to the control of this cellular function. Our results reveal that, in addition to the phospholipase C/Ca 2 þ /MLCK signalling pathway (reviewed in Reversi et al (2006) ), the RhoA/ROCK cascade has a major role in the control of OT-induced myoepithelial cell contraction. Most probably, upon OT ligation to its receptor, these two pathways operate in parallel, with MLCK directly phosphorylating MLC and ROCK inhibiting MLCP. The net outcome of MLCK and MLCP activities results in MLC phosphorylation and myoepithelial cell contraction. Further, the a3b1 integrinmediated cell-ECM adhesion leads to the activation of the FAK/Rac/PAK signalling pathway, and activated PAK phosphorylates and inhibits MLCK, resulting in the desensitization of myosin to Ca 2 þ and in the myoepithelial cell relaxation necessary for the completion of the contraction/ relaxation cycle and further contractions in response to pulsatile OT stimulation.
Previous studies have demonstrated that a3b1-deficient keratinocytes fail to form stable leading lamellipodia, consistent with the impairment of Rac pathway activation (Choma et al, 2004) . However, in this case, the abnormal phenotype is not rescued by the expression of constitutively active Rac, confirming that the physiological functions of individual integrin dimers are cell context dependent. Furthermore, in keratinocytes, the Rac guanine-exchange factor, Tiam1, has been shown to promote a3b1 integrinmediated cell spreading on laminin (Hamelers et al, 2005) . Figure 6 a3b1-mediated stimulation of the Rac/PAK pathway is required for completion of the myoepithelial cell contraction/ relaxation cycle. The contraction and relaxation of myoepithelial cells require MLC phosphorylation and dephosphorylation, respectively. The binding of OT to its receptor leads to MLC phosphorylation and myoepithelial cell contraction via activation of the phospholipase C/Ca 2 þ /calmodulin (CaM)/MLCK pathway and the Rho/ROCK signalling pathways. MLCK directly phosphorylates MLC, whereas ROCK inhibits MLCP (Somlyo and Somlyo, 2003) . The results of our study suggest that the engagement of a3b1 integrin leads to the activation of the FAK/Rac/PAK pathway and MLCK inhibition, thereby, permitting dephosphorylation of MLC and relaxation. In a3b1 integrin-deficient cells, Rac activation is impaired resulting in altered MLCK/MLCP activity balance and sustained MLC phosphorylation, preventing the accomplishment of the contraction/relaxation cycle.
The guanine-exchange factors acting downstream from a3b1 integrin in the control of Rac activation in myoepithelial cells remain to be determined.
Mammary myoepithelial cells express several different integrin dimers, but none seems to be able to substitute for a3b1 in activation of the Rac/PAK pathway. Flow cytometry analysis and adhesion assays showed no major change in the surface levels of other integrins or in the adhesion properties of a3b1-deficient cells, strongly suggesting that the observed phenotype results from the lack of a3b1, rather than from the upregulation of other integrin dimers.
Our findings are consistent with two recent studies reporting high rates of MLC phosphorylation and Rho activation in SM cells depleted of mediators of integrin signalling, such as a-parvin or integrin-linked kinase (ILK) (Kogata et al, 2009; Montanez et al, 2009 ). These studies suggested that the interaction of the ILK/a-parvin complex with b integrin cytoplasmic tail suppresses SM cell contractility, thereby serving as an important regulator of vascular morphogenesis (Wickström et al, 2010) . Although deregulation of the Rho/ Rac balance leading to cell hypercontractility seems to be a common feature between a3-deficient mammary myoepithelium and ILK or a-parvin-depleted vascular SM, a3b1 integrin deletion from the myoepithelial cell layer did not have any visible impact on the formation of the bilayered mammary epithelium. It seems plausible that signalling pathways controlled by a3b1 integrin and ILK/a-parvin complex do not overlap entirely. For instance, it has been suggested that ILK/a-parvin complex could differentially regulate signalling downstream of b3 and b1 integrins (Wickström et al, 2010) .
The reduced Rac activation in a3b1-deficient mammary tissue extract prepared from 1 day-lactating gland was associated with an increase in Rho activation. However, our experiments with cultured myoepithelial cells revealed a role for the Rac signalling pathway, downstream from a3b1 integrin, in the regulation of post-contraction relaxation, and suggested that a3b1 integrin per se had little or no impact on the Rho pathway activation. We found that a3b1-deficient cells responded to lower doses of OT than control cells. This phenomenon might result from higher levels of MLCK activity rather than increased levels of the Rho pathway activation in a3b1-deficient cells. The Rho and Rac pathways are known to have antagonistic roles in the regulation of various cellular functions, making important fine tuning of the Rho/Rac balance (Sander et al, 1999) . Elevated levels of active Rho observed in mutant gland extract may result from additional in vivo adaptation events associated with unaccomplished contraction/relaxation cycle.
Cell contraction results from the integration of forcegenerating processes driven by actomyosin, actin polymerization at the cell periphery and the binding of actin filaments to the ECM via integrins at focal adhesion sites. The molecular mechanisms underlying the mechanotransduction processes remain unclear, but it has been suggested that intracellular signalling events associated with focal adhesions regulate force transmission between cells and the ECM (Gunst and Zhang, 2008; Geiger et al, 2009; VincenteManzanares et al, 2009) . Our study provides the first in vivo evidence that a3b1 integrin-mediated signalling may contribute to the control of the amplitude and duration of the force developed by the cellular contractile apparatus in response to OT. This critical role in the regulation of OT-mediated contractility appears to be unique to a3b1 integrin and involves Rac-mediated signalling events.
Materials and methods
Mouse strains
All animal experiments were conducted in accordance with the French veterinary guidelines and Council of Europe guidelines for experimental animal use (L358-86/609EEC). The K5Cre mice were kindly provided by Dr J Jorcano (Ramirez et al, 2004) . The generation of mice carrying conditional a3 integrin alleles (itga3 F/F ) has been described elsewhere (Margadant et al, 2009) . Wild-type, itga3 F/ þ , itga3 F/F mice were used as control. Only females with litters of six to eight pups were selected for the analysis of mammary phenotype at lactation.
BrdU-incorporation test, tissue preparation, whole-mount staining, histology and immunostaining Mice were injected intraperitoneally with bromodeoxyuridine (BrdU), 0.25 mg/g of body weight, 2.5 h before tissue collection. Dissected mammary glands were either embedded into cryoprotectant (Tissue-Tek s O.C.T) and processed for cryosections (7 mm) and immunostained as previously described (Raymond et al, 2005) or spread onto a glass slide, fixed in MethaCarn and, either stained with Carmine alum in whole-mount, or embedded in paraffin. Sections (5-7 mm thick) were used for haematoxylin/eosin or immunofluorescence staining (Teulière et al, 2005) . Cells grown on glass coverslips were processed for immunostaining as previously described (Raymond et al, 2005) . Cell nuclei were stained with DAPI. The list of primary antibodies used for immunostaining is provided in the Supplementary data. All secondary antibodies and phalloidin were Alexafluor conjugated (Molecular Probes). The microphotographs shown in Figure 2D were acquired with Leica SP5 confocal microscope. Leica DM6000B microscope was used for other immunofluorescence images.
Evaluation of the OT effects on alveolar myoepithelial cell shape Mammary glands were processed as described elsewhere (Moore et al, 1987) . Briefly, glands were chopped finely with a scalpel in a buffer containing 136 mM NaCl, 1.2 mM NaH 2 PO 4 , 1.2 mM MgSO 4 , 5 mM KCl, 1.7 mM CaCl 2 , 1.1 mM glucose, 0.03 mM Na 2 EDTA, 10 mM Hepes, pH 7.2 and, when indicated 10 mM Y27632 (Calbiochem) for 10 min and then treated with 50 nM oxytocin (Tebu-bio) for 2 min at 371C. Tissue fragments of B1 mm 3 in size were subsequently fixed for 30 min in 4% paraformaldehyde, then for 5 min in 100% acetone at À201C, re-hydrated in PBS containing 1% BSA and incubated with the anti-keratin 5 antibody, phalloidin and DAPI. After incubation with the secondary antibody and washing, tissue fragments were mounted in Thermo Scientific Shandon Immu-Mount medium for observation under a Leica DM6000B microscope.
Quantitative RT-PCR RNA was isolated from the third mammary glands of 1 day-lactating females with the RNeasy kit (Quiagen Gmbh). Reverse transcription and quantitative PCR were performed as previously described (Taddei et al, 2008) . The sequences of the primers used are provided in the Supplementary data and in Taddei et al (2008) . The values were normalized to glyceraldehyde phosphate dehydrogenase expression levels using the comparative CT method.
Protein extracts, immunoprecipitation and immunoblotting
Proteins extracts were prepared from the fifth mammary glands of 1 day-lactating females. Tissue (125 mg/ml) was homogenized in lysis buffer (50 mM, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 0.1% SDS, 4 mM EDTA, 20 mM NaF, 2 mM sodium orthovanadate) containing a cocktail of protease inhibitors (Sigma-Aldrich). The extracts were cleared by centrifugation at 10 000 g at 41C for 15 min. For immunoprecipitation assays, 1 mg of protein extracts was preabsorbed with gammaBind Plus Sepharose beads (GE Healthcare) for 1 h at 41C on a vertical rotator, incubated for 1 h with 4 mg of primary antibody and for 2 h with gammaBind Plus Sepharose beads. The beads were then washed four times with lysis buffer, resuspended in reducing sample buffer for electrophoresis and boiled for 5 min. The supernatants were run on a NuPAGE s Novex s 4-12% Bis Tris gel (Invitrogen). After electrophoresis, proteins were transferred onto nitrocellulose. Membranes were successively incubated with 5% BSA in TBST (10 mM Tris, pH 8, 150 mM NaCl, 0.1% Tween 20) for 1 h at room temperature to block non-specific binding sites and with primary antibodies in TBST, overnight at 41C. Secondary antibodies coupled to horseradish peroxidase were purchased from Amersham. Detection was performed by chemiluminescence (Super Signal s west Pico chemiluminescent substrate, Pierce) using a Fuji Imager LAS3000. The list of the antibodies used for immunoprecipitation and immunoblotting is provided in the Supplementary data. Protein extracts from four control and mutant glands were analysed. Protein extracts from MEC were prepared as previously described (Raymond et al, 2005) and immunoblotting was performed as described above.
Establishment of MEC line, viral transduction, stable transfection and flow cytometry
The established MEC of itga3 F/F genotype was routinely maintained in low serum medium consisting of DMEM:F12 (Gibco-BRL) buffered with 15 mM Hepes, pH 7.6 (Sigma-Aldrich) containing 10 mg/ml insulin (Sigma-Aldrich), 5 ng/ml epidermal growth factor (Sigma-Aldrich), 0.5 mg/ml bovine serum albumin (SigmaAldrich), 5 mg/ml linoleic acid complex (Sigma-Aldrich), 2% calf serum (HyClone), 50 mg/ml gentamycin (Sigma-Aldrich) and 20 U/ml nystatin (Sigma-Aldrich). The line was established as previously described (Medina and Kittrell, 2000) . In brief, primary mammary epithelial cells obtained by collagenase/hyaluronidase digestion of inguinal glands from 16 day-pregnant itga3 F/F females were seeded into matrigel in low serum medium defined above. After 4 weeks of growth, the cells were recovered from matrigel using dispase, plated on collagen-coated plastic and maintained in culture. After B2 months, when most cells became senescent, and only few clones were capable of expanding, the proliferating cell clones were harvested and amplified. The cell clone stably expressing myoepithelial cell markers and negative for mammary luminal markers was chosen for further studies (Supplementary Figure S3) . Cre-mediated deletion of itga3 F/F alleles was performed as described previously (Raymond et al, 2005) . Retroviral transduction was performed as described elsewhere (Sterk et al, 2000) , and infected cells were subsequently maintained under G418 selection (500 mg/ml; #ant-gn-5, Invivogen). The retroviral construct myc-Rac V12 cloned in pLZRS-MS-IRES-Neo/pBR was kindly provided by Dr JG Collard. Stable transfections were performed with Lipofectamin TM 2000 (#11 668, Invitrogen) according to the manufacturer's instructions. The pCAG-Myc-PAK-CAAX-IRES-GFP, pCAG-Myc-PAK-R299-CAAX-IRES-GFP and pCDNA-GFP-Rac N17 vectors provided by Dr M Nicolic (Jacobs et al, 2007) and Dr A Gautreau, respectively, were co-transfected with pGK puro plasmid. Transfected cells were selected using puromycin (10 mg/ml, #ant-pr-5, Invivogen), and the bulk population of cells was analysed in all cases. The aPAK shRNA and control shRNA plasmids were from Santa Cruz Biotechnology (036SC-270016-SH and sc-108060). Transfections were performed according to the manufacturer's instructions. Flow cytometry and cell sorting were performed, respectively, on BD FACSCalibur and FACSvantage (Becton Dickinson) flow cytometers, as previously described (Margadant et al, 2009 ).
Time-lapse video microscopy
For video microscopy, sparse cell cultures were grown on glassbottomed microwell dishes (MatTek Corporation) for 16-20 h.
Time-lapse video microscopy (one image captured per min) was performed on Time Lapse Imaging System Biostation IM (Nikon Corporation) with an integrated incubation system (371C, 5% CO 2 ). MLCK inhibitor (ML7) was used at concentrations of 1 mM and 10 mM, ROCK inhibitor (Y27632) at 10 mM; Rac1 inhibitor (NCS23766) at 100 mM; Myosin ATPase inhibitor (blebbistatin) at 25 mM (all from Calbiochem). OT (1 nM, or as indicated; Tebu-bio) was added 45-120 min after inhibitor and the response was followed during 60 min. Planar surface area was measured as readout for contractile responsiveness with Image J software. Initial surface area was defined as a mean value over 15 min. Spontaneous cell surface area fluctuation did not exceed 9.6%. A decrease in surface area was considered as contraction when the cell surface area was p72% of the initial area. Cells with a surface area of at least 86% of the initial surface area were considered as relaxed. Cells that were not spreading (showing refringent borders), abnormally large (usually polynucleated) or dividing, and cells that did not remain stable during the 15 min preceding the addition of OT were excluded from the analysis. The data obtained in four independent experiments are presented.
Rho-GTPases activation assay
Quantification of Rac and RhoA activation was performed using G-LISA Rac and RhoA Activation Assay Biochem Kits, following the manufacturer's instructions (Cytoskeleton, Inc.).
Statistical analysis
Statistical analysis was performed with Prism 4 software (GraphPad) using Mann-Whitney U test for the comparison of two groups except in Figure 2E where unpaired t-test was used. A value of *Po0.05, **Po0.01 or ***Po0.001 denoted statistical significance.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
